Health Products

Cefoxitine for Injection (2015-04-24)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
0001D4
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court,
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court,
Toronto
M1B 2K9
Ontario
CANADA
B. Cefoxitine for Injection 10 g/vialPowder for SolutionDIN 02240773Cefoxitin (Cefoxitin sodium) 10 g/vial
0001D4
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court,
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court,
Toronto
M1B 2K9
Ontario
CANADA
A. Cefoxitine for Injection 1 g/vialPowder for SolutionDIN 02128187Cefoxitin (Cefoxitin sodium) 1 g/vial

Introduction

Recalled Products

A. Cefoxitine for Injection 1 g/vial

B. Cefoxitine for Injection 10 g/vial

Reason

Possible presence of dark particles of Active Pharmaceutical Ingredient (API) in the vials, observed only after reconstitution.

Depth of distribution

Wholesalers, retailers and hospitals

For more information

Dear Healthcare Professional Letter: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53139a-eng.php
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime